CME Group Inc. (CME) Income Statement
CME 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsCME revenue and net income
Where CME's revenue goes
2025Each bar shows an amount and its share of revenue. CME kept 62.0% of revenue as net income.
CME profit margins
CME growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +6.4% | +9.1% | +6.0% | +7.0% |
| Gross profit | +6.3% | +9.6% | +6.9% | +7.4% |
| Operating income | +7.6% | +11.9% | +9.9% | +7.8% |
| Net income | +14.7% | +14.5% | +13.9% | +12.5% |
| EPS (diluted) | +9.3% | +12.0% | +10.7% | +11.2% |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
CME quarterly EPS vs estimates
CME Group beat the analyst EPS estimate in 6 of the last 8 quarters. Next report: October 21, 2026 (estimate $2.98).
CME income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.52B | $6.13B | $5.58B | $5.02B | $4.69B | $4.88B | $4.87B | $4.31B | $3.64B | $3.60B |
| Cost of revenue | $907.0M | $850.3M | $828.6M | $753.1M | $837.0M | $856.5M | $898.7M | $672.2M | $563.9M | $543.2M |
| Gross profit | $5.61B | $5.28B | $4.75B | $4.27B | $3.85B | $4.03B | $3.97B | $3.64B | $3.08B | $3.05B |
| Research & development | — | — | $218.7M | $188.6M | $192.6M | $198.5M | $201.5M | $117.2M | $101.6M | $97.6M |
| Sales, general & admin | $150.5M | $132.7M | $1.03B | $137.4M | $151.7M | $191.3M | $174.1M | $166.1M | $117.6M | $144.4M |
| Total operating expenses | $1.38B | $1.35B | $1.31B | $1.25B | $1.21B | $1.39B | $1.38B | $1.03B | $745.9M | $824.7M |
| Operating income | $4.23B | $3.93B | $3.44B | $3.02B | $2.65B | $2.64B | $2.59B | $2.61B | $2.31B | $2.20B |
| Interest income | — | — | — | — | — | — | $636.7M | $740.2M | $543.9M | $128.5M |
| Interest expense | $129.7M | $160.9M | $159.4M | $162.7M | $166.9M | $166.2M | $178.0M | $157.7M | $117.0M | $123.5M |
| Income before taxes | $5.33B | $4.54B | $4.15B | $3.49B | $3.37B | $2.72B | $2.69B | $2.78B | $2.53B | $2.29B |
| Income taxes | $1.27B | $1.02B | $927.4M | $799.3M | $736.7M | $615.7M | $573.8M | $814.1M | −$1.54B | $753.5M |
| Net income | $4.04B | $3.53B | $3.23B | $2.69B | $2.64B | $2.11B | $2.12B | $1.96B | $4.06B | $1.53B |
| EBITDA | $5.78B | $5.04B | $4.67B | $4.02B | $3.93B | $3.35B | $3.34B | $3.18B | $2.85B | $2.64B |
| EPS (diluted) | $11.21 | $10.26 | $9.34 | $7.98 | $6.69 | $6.73 | $6.80 | $6.82 | $4.76 | $4.43 |
| Gross margin | 86.1% | 86.1% | 85.1% | 85.0% | 82.2% | 82.5% | 81.5% | 84.4% | 84.5% | 84.9% |
| Operating margin | 64.9% | 64.1% | 61.6% | 60.1% | 56.4% | 54.0% | 53.2% | 60.5% | 63.4% | 61.2% |
| Net margin | 62.0% | 57.5% | 57.8% | 53.6% | 56.2% | 43.1% | 43.5% | 45.5% | 111.5% | 42.7% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.71B | $1.88B | $1.65B | $1.54B | $1.69B | $1.64B | $1.53B | $1.58B | $1.53B | $1.49B | $1.44B | $1.34B |
| Cost of revenue | $524.7M | $223.0M | $241.1M | $237.6M | $221.6M | $206.7M | $220.8M | $218.8M | $204.7M | $206.0M | $212.9M | $205.5M |
| Gross profit | $1.18B | $1.66B | $1.41B | $1.30B | $1.47B | $1.44B | $1.30B | $1.37B | $1.33B | $1.28B | $1.23B | $1.13B |
| Research & development | — | — | — | — | — | — | — | $66.6M | $64.1M | $59.4M | $58.5M | $55.6M |
| Sales, general & admin | $29.1M | $28.2M | $47.9M | $36.7M | $37.4M | $28.5M | $33.9M | $67.8M | $252.7M | $33.1M | $36.1M | $32.2M |
| Total operating expenses | $74.4M | $347.4M | $388.0M | $327.4M | $341.1M | $327.6M | $357.4M | $341.4M | $327.2M | $322.3M | $363.2M | $312.1M |
| Operating income | $1.11B | $1.31B | $1.02B | $972.6M | $1.13B | $1.11B | $947.1M | $1.02B | $1.00B | $959.6M | $863.2M | $820.2M |
| Interest expense | $43.6M | $43.6M | $43.7M | $44.0M | $44.0M | $41.7M | $40.7M | $40.2M | $40.1M | $39.9M | $39.7M | $39.6M |
| Income before taxes | $1.33B | $1.51B | $1.58B | $1.18B | $1.33B | $1.24B | $1.10B | $1.18B | $1.15B | $1.11B | $1.01B | $974.3M |
| Income taxes | $285.9M | $356.6M | $410.4M | $269.0M | $305.2M | $288.6M | $222.0M | $264.1M | $271.3M | $258.2M | $191.4M | $224.1M |
| Net income | $1.04B | $1.15B | $1.17B | $908.0M | $1.01B | $956.2M | $874.6M | $912.8M | $883.2M | $855.2M | $814.6M | $750.2M |
| EBITDA | $946.5M | $1.64B | $1.65B | $1.30B | $1.46B | $1.37B | $1.22B | $1.30B | $1.28B | $1.24B | $1.13B | $1.10B |
| EPS (diluted) | $2.99 | $3.36 | $2.77 | $2.68 | $2.96 | $2.80 | $2.52 | $2.68 | $2.56 | $2.50 | $2.37 | $2.25 |
| Gross margin | 69.2% | 88.1% | 85.4% | 84.5% | 86.9% | 87.4% | 85.5% | 86.2% | 86.6% | 86.2% | 85.2% | 84.6% |
| Operating margin | 64.9% | 69.7% | 61.8% | 63.3% | 66.7% | 67.5% | 62.1% | 64.6% | 65.3% | 64.5% | 60.0% | 61.3% |
| Net margin | 61.1% | 61.4% | 70.8% | 59.1% | 59.8% | 58.2% | 57.3% | 57.6% | 57.6% | 57.5% | 56.6% | 56.1% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in CME's financial statements (latest annual report filed February 26, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
CME financial results
In fiscal year 2025 (ended December 31, 2025), CME Group reported revenue of $6.5 billion, up 6.4% from the year before. It had net income of $4.0 billion (up 14.7%), a net profit margin of 62.0%. Diluted earnings per share came to $11.21. Over five years revenue grew at an average rate of 6.0% a year.
See the CME stock overview for the latest quote and news, or the CME chart for price history and technical indicators.
CME income statement FAQ
What is CME Group's annual revenue?
CME Group reported total revenue of $6.5 billion for fiscal year 2025, which ended on December 31, 2025. That was up 6.4% from $6.1 billion the previous year.
Is CME Group profitable?
Yes. CME Group reported net income of $4.0 billion in fiscal 2025, a net profit margin of 62.0%; its operating margin was 64.9%.
What is CME Group's gross margin?
CME Group's gross margin was 86.1% in fiscal 2025: for every $100 of revenue, CME Group kept $86 after the direct cost of its products and services.
How fast is CME Group growing?
Revenue grew 6.0% a year on average over the last five fiscal years, from $4.9 billion to $6.5 billion.
What are CME Group's earnings per share?
CME Group earned $11.21 per diluted share in fiscal 2025, compared with $10.26 a year earlier.
When will CME Group report its next earnings?
CME Group is expected to report results for the quarter ending September 30, 2026 on October 21, 2026 before the market opens.
When does CME Group's fiscal year end?
CME Group's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 26, 2026.